English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The improved analytical characteristics of both sensitive and high-sensitivity assays for cardiac troponins I (cTnI)3 and T (cTnT) have substantially increased the diagnostic sensitivity for early detection of acute myocardial infarction (AMI) (1–3). With the ability to detect small increases in circulating cardiac troponins, any cause of myocardial injury will now produce a substantially greater number of analytically true positive findings not detectable by earlier generations of cardiac troponin assays (3–6). This evolution has led to a decrease in diagnostic specificity for the diagnosis of AMI, a concern to many clinicians who may incorrectly equate any increased cardiac troponin value to an AMI (7, 8). Observational studies, although conducted predominately with prior-generation assays, have consistently demonstrated that any increase in cardiac troponin due to almost any mechanism of myocardial injury carries an association with worse outcomes (3, 7). Nevertheless, because diagnostic specificity is pivotal to appropriate therapy, pragmatic approaches are needed to sustain diagnostic specificity with sensitive and high-sensitivity assays for cardiac troponin. In this issue of Clinical Chemistry , Mueller and colleagues (9) report on their experience with one such approach that uses the change in cardiac troponin over time (δ).First proposed by Fesmire in 2000 (10), diagnostic algorithms based on the δ cardiac troponin have now been shown in several studies to improve diagnostic specificity, but not necessarily diagnostic sensitivity (11–13). When a sensitive contemporary assay (Ortho Clinical Diagnostics Vitros ES cTnI) was used, a 6-h δ based on an optimized 30% change improved diagnostic specificity from 77% to 91%, whereas diagnostic sensitivity changed from 94% based on the 99th-percentile value, compared with 75% based on the δ value (11). More recently, using the high-sensitivity cTnT assay (hs-cTnT), Reichlin and coworkers observed that a criterion of an absolute …

Delta Cardiac Troponin Values in Practice: Are We Ready to Move Absolutely Forward to Clinical Routine?